Fox Chase Cancer Center News

Elizabeth Handorf, PhD
January 17, 2019

New Algorithm Improves Reliability of Online Survey Data

PHILADELPHIA (January 17, 2019) — Elizabeth Handorf, PhD, has developed a new method that makes analysis of data collected online more reliable by eliminating repeat responders. 

microbiota.  Sergei Grivennikov, PhD, assistant professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, and his team investigated the role that signaling by cytokine interleukin-1 (IL-1) plays in tumor formation. They found that cytokine signals elicit distinct, cell type-specific responses, and that these responses influence the overall inflammatory tone of the tumor microenvironment and direct tumor promotion.
January 15, 2019

Research Traces Mechanisms Involving Cytokines, Inflammation, and Intestinal Microbiota that Impact Colorectal Tumor Growth

PHILADELPHIA (January 15, 2019) — Fox Chase Cancer Center researchers have found important and unexpected relationships between cytokines, tumor-elicited inflammation and the role of intestinal microbiota.

January 15, 2019

Improved Understanding of Renal Cell Cancer Mutations and Identification of Biomarkers May Inform Future Treatment Options

PHILADELPHIA (January 15, 2019) — There is an opportunity to make a greater difference by identifying biomarkers and mutations that will help oncologists select the most effective treatments for individual patients.

January 11, 2019

Researchers Mine Administrative Databases to Uncover Valuable Research Focused on Non-Prostate Genitourinary Cancer Treatments

PHILADELPHIA (January 11, 2019) — Readily available administrative databases are a cost-effective tool for investigating treatments for non-prostate genitourinary cancer and identifying research gaps and novel therapies, 

January 10, 2019

Thomas Jefferson University and Temple University Enter Exclusive Negotiations

Jefferson to pursue purchase of Fox Chase Cancer Center

Two of Philadelphia’s leading academic and healthcare organizations have signed an agreement that creates an exclusive 90-day window within which to consider and negotiate the acquisition and conduct due diligence by Jefferson of the Fox Chase Cancer Center.

The move opens the door to bring together significant complementary expertise in cancer treatment and breakthrough research to improve patient outcomes across the greater Philadelphia region and beyond.

January 8, 2019

New Members of MiT Family Translocation Renal Cell Carcinoma Identified at Fox Chase Cancer Center

PHILADELPHIA (January 8, 2019) — Using next-generation sequencing (NGS) based RNA-sequencing, researchers at Fox Chase Cancer Center identified two new members of MiT family translocation renal cell carcinoma, NEAT1-TFE3 and KAT6A-TFE3, further emphasizing the genetic complexity of this group of renal tumors.

Edna Cukierman, PhD
January 8, 2019

Altering the Supportive Structure of Pancreatic Cancer Tissue May Unlock Promising Therapies

PHILADELPHIA (January 8, 2019) — Fox Chase Cancer Center researchers are exploring the structural mechanisms that allows pancreatic ductal adenocarcinoma (PDAC) to spread, and a new paper suggests that altering underlying substrates could harness the body’s ability to restrict the disease’s progress.

January 7, 2019

Fox Chase Cancer Center Advises Individuals on How to Reduce Your Risk for Cancer

The beginning of the New Year is a perfect time to reflect on your health and to learn ways you can reduce your risk for cancer. 


Connect with Fox Chase